UCSF

ZINC03973334

Substance Information

In ZINC since Heavy atoms Benign functionality
October 28th, 2005 22 No

CAS Numbers: 107868-30-4 , [107868-30-4]

Other Names:

(8R,9S,10R,13S,14S)-10,13-Dimethyl-6-methylene-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17(10H,14H)-dione

(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione

mestane

107868-30-4

107868-30-4; Aromasin (TN); D00963; Exemestane (JAN/USP/INN)

107868-30-4; C08162; Exemestane

6-Methylenandrosta-1,4-diene-3,17-dione

6-Methylene-androsta-1,4-diene-3,17-dione

6-methyleneandrosta-1,4-diene-3,17-dione

6-methyleneandrosta-1,4-diene-3,17-dione; AROMASIN; Androsta-1,4-diene-3,17-dione, 6-methylene-; C20H24O2; EXEMESTANE; Exemestane [USAN:INN:BAN]; Exemestano [INN-Spanish]; Exemestanum [INN-Latin]; FCE 24304; FCE-24304; HSDB 7463; LS-19329

6-methyleneandrosta-1,4-diene-3,17-dione; Exemestane

6-methylideneandrosta-1,4-diene-3,17-dione

AC-2171

AC1L1SRB

AC1Q6AAZ

Ambap107868-30-4

Androsta-1,4-diene-3,17-dione, 6-methylene-

Aromasil

Aromasin

Aromasin (TN)

Aromasin, Exemestane

Aromasine

BAN

C056516

C08162

CHEBI:4953

CHEMBL1200374

CID60198

CPD000466314

CPD000466314; EXEMESTANE

CPD000466314; EXEMESTANE; SAM001246574

Curator_000009

D00963

DAP000625

DB00990

EXE

Exemestance

Exemestane (BAN

Exemestane (FDA

Exemestane (JAN/USP/INN)

Exemestane [USAN:INN:BAN]

Exemestane-13C-d4

exemestane; exemestano; exemestanum

Exemestano

Exemestano [INN-Spanish]

Exemestano [INN-Spanish];Exemestanum [INN-Latin]

Exemestanum

Exemestanum [INN-Latin]

Fce 24304

FCE-24304

FCE-24304; PNU-155971

FDA

HMS2051J04

HSDB 7463

INN

LS-19329

MFCD00866994

MFCD18711340

MLS000759419

MLS001424062

MolPort-003-847-343

Nikidess

NSC713563

Pfizer brand of exemestane

PNU-155971

S1196_Selleck

S1196_Sellek

SAM001246574

SMR000466314

UNII-NY22HMQ4BX

USAN)

ZINC03973334

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 3.35 9.64 -12.45 0 2 0 34 296.41 0

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 6.83e-03 g/l DrugBank-approved
Purity 95% Fluorochem
Therapy antineoplastic, aromatase inhibitor SMDC Pharmakon
Target Aromatase Selleck Chemicals
Indications breast cancer KeyOrganics Bioactives
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP03000e NIH Clinical Collection via PubChem
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP03000e NIH Clinical Collection via PubChem
Purity USP24 APIChem

Activity (Go SEA)

Analogs ( Draw Identity 99% 90% 80% 70% )